Joshi Abhay Insider Trades

Insider Trading History

Track insider trading activity for Joshi Abhay. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President Of R&d
Holding Value $441k 120,708 shares
Last Trade
Mar 15, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$41.2k 2,607 shares
$15.79
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President, R&d
Holding Value $461k 126,217 shares
Last Trade
Feb 15, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.5k 5,053 shares
$13.35
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President, R&d
Holding Value $469k 128,368 shares
Last Trade
Mar 15, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37.5k 1,354 shares
$27.73
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President, R&d
Holding Value $484k 132,603 shares
Last Trade
Feb 15, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$140k 4,848 shares
$28.97
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President, R&d
Holding Value $491k 134,570 shares
Last Trade
Feb 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 63,545 shares
$28.01
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President, R&d
Holding Value $409k 111,950 shares
Last Trade
Sep 30, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$186k 7,382 shares
$25.14
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President, R&d
Holding Value $436k 119,332 shares
Last Trade
Sep 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$440k 17,500 shares
$25.14
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President Of R&d
Holding Value $372k 101,832 shares
Last Trade
Mar 15, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21k 1,354 shares
$15.50
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Coo, President, R&d
Holding Value $377k 103,186 shares
Last Trade
Feb 15, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$84.2k 3,325 shares
$25.33
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $535k 146,500 shares
Last Trade
Jan 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.83M 171,500 shares
$22.32
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $298k 81,511 shares
Last Trade
Jan 15, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$102k 4,441 shares
$22.89
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $314k 85,952 shares
Last Trade
Dec 14, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$47.5k 2,971 shares
$15.99
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $325k 88,923 shares
Last Trade
Mar 15, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20.9k 1,354 shares
$15.45
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $330k 90,443 shares
Last Trade
Mar 14, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.4k 666 shares
$15.57
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $330k 90,277 shares
Last Trade
Mar 14, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.59k 166 shares
$15.59
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 14, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.4k 666 shares
$15.57
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $328k 89,777 shares
Last Trade
Feb 15, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.7k 1,510 shares
$17.69
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $343k 94,000 shares
Last Trade
Jan 24, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.89M 109,750 shares
$17.23
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $276k 75,537 shares
Last Trade
Jan 15, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$90.2k 4,466 shares
$20.19
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Chief Operating Officer
Holding Value $292k 80,003 shares
Last Trade
Dec 14, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$84.8k 4,260 shares
$19.91
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up